![logo](/logos/SRRK.webp)
Scholar Rock Holding Corporation
NASDAQ:SRRK
8.03 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Scholar Rock Holding Corporation |
Symbool | SRRK |
Munteenheid | USD |
Prijs | 8.03 |
Beurswaarde | 642,661,778 |
Dividendpercentage | 0% |
52-weken bereik | 5.94 - 21.17 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jay T. Backstrom M.D., M.P.H. |
Website | https://scholarrock.com |
An error occurred while fetching data.
Over Scholar Rock Holding Corporation
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)